253
Participants
Start Date
November 30, 2013
Primary Completion Date
January 31, 2015
Study Completion Date
February 28, 2015
REGN1033 (SAR391786)
placebo
Anniston
Phoenix
El Cajon
Garden Grove
Laguna Hills
San Francisco
Walnut Creek
Aurora
Gainesville
Jacksonville
Jupiter
Orlando
South Miami
Chicago
Baton Rouge
College Park
Elkridge
Boston
Edina
Omaha
Albuquerque
High Point
Winston-Salem
Athens
Columbus
Duncansville
Spartanburg
Dallas
Plano
San Antonio
Salt Lake City
West Jordan
Richmond
Limoges
Montpellier
Saint-Etienne
Toulouse
Amsterdam
Leeuwarden
Noord-Brabant
Albacete
L'Hospitalet de Llobregat
Madrid
Collaborators (1)
Sanofi
INDUSTRY
Regeneron Pharmaceuticals
INDUSTRY